EnBiotix: Polyphor's Merger Agreement With EnBiotix
VISCHER AG advises Polyphor AG on the deal. Polyphor (SIX: POLN) and EnBiotix Inc., a privately held late clinical-stage rare disease company currently focused on products [...]
Read full article »
EnBiotix is a Massachusetts-based biotechnology firm that develops and commercializes therapies for the treatment of chronic respiratory disorders.
Read more